Provided by Tiger Trade Technology Pte. Ltd.

Rezolute, Inc.

3.98
-0.1700-4.10%
Post-market: 3.97-0.0100-0.25%19:30 EDT
Volume:2.05M
Turnover:8.23M
Market Cap:383.24M
PE:-4.95
High:4.23
Open:4.20
Low:3.88
Close:4.15
52wk High:11.46
52wk Low:1.07
Shares:96.29M
Float Shares:72.51M
Volume Ratio:1.42
T/O Rate:2.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8039
EPS(LYR):-0.9791
ROE:-81.73%
ROA:-48.74%
PB:3.28
PE(LYR):-4.06

Loading ...

Top News Today/Canada: Inflation Holds Steady at 3%

Dow Jones
·
Sep 15

Rezolute, Inc. Expected to Post a Loss of 15 Cents a Share - Earnings Preview

Reuters
·
Sep 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 10

Rezolute Says FDA Review Continues for Phase 3 sunRIZE Data on Ersodetug in Congenital Hyperinsulinism

Reuters
·
Sep 09

Rezolute, - Open-Label Extension Phase Ongoing with High Participation and Improved Glycemic Control

THOMSON REUTERS
·
Sep 09

Rezolute, - Enrollment Ongoing in Phase 3 Uplift Study for Tumor Hi; Results Expected Before End of 2026

THOMSON REUTERS
·
Sep 09

Rezolute, - FDA Still Reviewing Submission for Regulatory Path Forward for Ersodetug in Congenital Hi

THOMSON REUTERS
·
Sep 09

Rezolute Provides Update on FDA Review of Its Phase 3 Sunrize Study Results in Congenital Hyperinsulinism

THOMSON REUTERS
·
Sep 09

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 04

Rezolute Says Cash Position Totals $120 Million, Funds Operations into Mid-2028

Reuters
·
Aug 26

Rezolute Shares to Show Strength Towards Upcoming Ersodetug Catalysts, Wedbush Says

MT Newswires Live
·
Aug 25

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Boston Scientific (BSX)

TIPRANKS
·
Jul 30

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
Jul 14

Vivani Stock Puts These Obesity And Diabetes Treatment Stocks On The Radar

Simply Wall St.
·
Jul 12

Rezolute Posts Corporate Deck on Phase 3 Ersodetug Program for Refractory Hypoglycemia in Hyperinsulinism

Reuters
·
Jun 27

Rezolute highlights Phase 3 sunRIZE data for ersodetug in congenital hyperinsulinism at ENDO meeting

Reuters
·
Jun 17

Rezolute Is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 15

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Vericel (VCEL)

TIPRANKS
·
Jun 10

Craig-Hallum Keeps Their Hold Rating on Rezolute (RZLT)

TIPRANKS
·
Jun 05